NALP1/NLRP1 genetic variants are associated with Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 3, 2012, Pages 277-281

  Pontillo, Alessandra ^a   Catamo, Eulalia ^b   Arosio, Beatrice ^c   Mari, Daniela ^c   Crovella, Sergio ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer disease; inflammasome; NALP1 NLRP1; polymorphism

Indexed keywords

NALP1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FUNCTIONAL STATUS; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOPTOSIS REGULATORY PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84862662191     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318231a8ac     Document Type: Article

References (24)

1. Salminen A, Ojala J, Suuronen T, et al. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med. 2008;12(6A):2255-2262.
2. Lamkanfi M, Dixit VM. Inflammasomes: Guardians of cytosolic sanctity. Immunol Rev. 2009;227:95-105.
3. Kummer JA, Broekhuizen R, Everett H, et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem. 2007;55:443-452.
4. de Rivero Vaccari JP, Lotocki G, Alonso OF, et al. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab. 2009;29:1251-1261.
5. Waring SC, Rosenberg RN. Genome-wide association studies in Alzheimer disease. Arch Neurol. 2008;65:329-334.
6. McKhan G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology. 1984;34:939-944.
7. Bianchi A, Dai Pra M. Twenty years after Spinnler and Tognoni: new instruments in the Italian neuropsychologist's toolbox. Neurol Sci. 2008;29:209-217.
8. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
9. Daum I, Riesch G, Sartori G, et al. Semantic memory impairment in Alzheimer's disease. J Clin Exp Neuropsychol. 1996;18:648-665.
10. Sunderland T, Hill JL, Mellow AM, et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37:725-729.
11. Appollonio I, Gori C, Riva G, et al. Assessing early to late stage dementia: The TSI and BANS-S scales in the nursinghome. Int J Geriatr Psychiatry. 2005;20:1138-1145.
12. Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist. 1970;10:20-30.
13. Lawton MP, Brody EM. Assessment of older people: selfmaintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186.
14. Cummings JL. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology. 1997;48(5
15. Suppl 6):S10-S16.
16. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res. 1982-1983;17:37-49.
17. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligoassociated multiple autoimmune disease. N Engl J Med. 2007;356:1216-1225.
18. Magitta NF, Be Wolff AS, Johansson S, et al. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun. 2009;10:120-124.
19. Barrett JC, Fry B, Maller J, et al. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
20. Liu F, Lo CF, Ning X, et al. Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. Cell Signal. 2004;16:1013-1021.
21. Aksentijevich I, Putnam CI, Remmers EF, et al. The Clinical Continuum of Cryopyrinopathies - Novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56:1273-1285.
22. Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer's disease: An update. Ann Med. 2008;40: 562-583.
23. Burns A, Iliffe S. Alzheimer's disease. BMJ. 2009;338:b158.
24. Carrasquillo MM, Belbin O, Hunter TA, et al. Replication of CLU, CR1, and PICALM associations with Alzheimer Disease. Arch Neurol. 2010;67:961-964.